Concord Biotech Limited has informed the Exchange about Change in Company Secretary/Compliance Officer
CONCORDBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Concord Biotech Limited has informed the stock exchange about a change in the position of Company Secretary and Compliance Officer. The Company Secretary is a key managerial personnel (KMP) responsible for regulatory compliance, board coordination, and shareholder communications. The announcement does not specify whether the change is due to a resignation, appointment, or replacement, nor does it name the incoming or outgoing person. No financial impact or reason for the change has been disclosed in the headline.
Routine governance update — Company Secretary changes are common and usually have no direct impact on stock price or operations, though shareholders may want to monitor who takes on the compliance role.